Belvedere Trading’s GeneDx Holdings WGS Stock Holding History

Belvedere Trading’s Portfolio WGS Stock Details WGS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-142	Closed	-$15K	–	648
2021 Q4	$15K	Sell	142 -149	-51%	-$33.3K	﹤0.01%	409
2021 Q3	$71K	Buy	+291	New	+$99.9K	﹤0.01%	391

Other funds holding WGS

Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

SB Management Abu Dhabi, United Arab Emirates $516M AUM 40.71% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Corvex Management New York $3.27B AUM 38.53% 1-Year Est. Return

Third Point New York $4.68B AUM 37.3% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

DCMIC

Decheng Capital Management III (Cayman) Grand Cayman, Cayman Islands $300M AUM 15.74% 1-Year Est. Return

Belvedere Trading's WGS Position: Q1 2022 in Review

Belvedere Trading sold out of GeneDx Holdings (WGS) in Q1 2022, closing a stake of 142 shares — an estimated $15K sold.

Belvedere Trading first reported a position in WGS in Q3 2021 and held it in 2 quarters. The position peaked at $71K in Q3 2021. 108 funds tracked by Wall St. Rank hold WGS as of Q1 2022.

Belvedere Trading reported no remaining GeneDx Holdings position as of Q1 2022 after selling out during the quarter.
Belvedere Trading sold 142 GeneDx Holdings shares in Q1 2022, an estimated $15K.
Belvedere Trading first reported a position in GeneDx Holdings in Q3 2021 and held it in 2 quarters.
Belvedere Trading's GeneDx Holdings position peaked at $71K in Q3 2021.
108 funds tracked by Wall St. Rank held GeneDx Holdings as of Q1 2022.

Based on Belvedere Trading's 13F filing for Q1 2022, filed 20 Apr 2022.